CNBCLean R·
Cramer: I asked some tech insiders what to buy. They surprisingly said this drug stock
Looking beyond AI for the next big winner? This drug stock could be headed for a $2 trillion valuation.
Read at CNBC →
Looking beyond AI for the next big winner? This drug stock could be headed for a $2 trillion valuation.
<iframe src="https://statesidedaily.com/embed/cluster/d7cb96b57b778d4bf9bd0c6cd57eec65475464a9" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Cramer: I asked some tech insiders what to buy. They surprisingly said this drug stock"></iframe>